- A Simple, Non-Invasive Test 'Menocheck(R)' is Now Available at Rite Aid Stores!
Synova Healthcare Group, Inc. (SNVH) announced today that it has received an initial opening order for Menocheck(R) from the Rite Aid Corporation. Rite Aid is one of the nation's leading drugstore chains and currently operates approximately 3,400 stores in 28 states and the District of Columbia. Consumers shopping for Menocheck(R) at Rite Aid stores will find the product arriving on store shelves throughout the month of June.
Menocheck(R) is a simple at-home urine test that allows women to accurately check for the onset of menopause in the privacy of their own home. It detects elevated levels of a hormone known as follicle stimulating hormone (FSH), which becomes elevated with the onset of menopause. Each Menocheck(R) -- Menopause Indicator Test package comes with two individually wrapped test devices, which are used five to seven days apart in order to confirm that FSH levels have remained elevated over the testing period. Two positive Menocheck(R) test results are then suggestive of the onset of menopause, and women are encouraged to take these findings to their health care providers in order to discuss potential treatment plans as they enter this phase of life.
Early detection of the onset of menopause is an important first step to improved quality of life and long term health for the millions of American women who enter menopause annually. In the medical community, it is a well known fact that menopausal women are at a greater risk for diseases such as osteoporosis and cardiovascular disease. Menocheck(R) is easy-to-use and offers women the convenience of a one-step at-home test, and is a non-invasive alternative to clinical blood testing for initial menopause screenings.
Introduced in late 2003, Menocheck(R) was the first over the counter menopause indicator test to have been made commercially available through retail pharmacies. "We are very pleased to now be adding Rite Aid stores to our impressive list of fine retailers that offer Menocheck(R) for sale", stated company President, Mr. David Harrison. Synova's growing retail distribution network for Menocheck(R) already includes leading retailers like Walgreens, Albertsons, Eckerd, Duane Reed, Kroger, Longs Drugs and Happy Harry's locations.
About Menocheck(R): --------------------
Non-invasive and similar to an at-home pregnancy test in design, Menocheck(R) works by measuring the level of follicle stimulating hormone (FSH) in the urine. As women enter menopause, FSH levels gradually rise and stay permanently higher once menopause has set in. Menocheck(R) is FDA approved.
Each Menocheck(R) package includes two test devices and simple-to-follow instructions, and when used as directed has been shown to be *99% accurate. Menocheck(R) typically retails for $19.99, and is now widely available at fine retailers nationwide. For more information about menopause and Menocheck(R) consumers can visit http://www.menocheck.com/ .
* 99% accuracy agreement in studies conducted with consumers/lay persons About Synova Healthcare, Inc.: ------------------------
Synova Healthcare Inc., a wholly owned subsidiary of Synova Healthcare Group, Inc. (SNVH), distributes rapid, non-invasive medical diagnostics at retail for over-the-counter (OTC) use, and direct to health care providers for point of care (POC) use in the clinical setting. The company's products improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Source: Synova Healthcare Group, Inc.
CONTACT: Synova Healthcare, Inc. Corporate Contact Information,
+1-610-565-7080, or fax, +1-610-565-7081, Inquiries:
customerservice@synovahealthcar
Web site: http://www.synovahealthcare
http://www.menocheck.com/